1. Home
  2. BRLT vs NMTC Comparison

BRLT vs NMTC Comparison

Compare BRLT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brilliant Earth Group Inc.

BRLT

Brilliant Earth Group Inc.

HOLD

Current Price

$1.54

Market Cap

36.6M

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.70

Market Cap

34.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRLT
NMTC
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.6M
34.3M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
BRLT
NMTC
Price
$1.54
$0.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$2.23
AVG Volume (30 Days)
74.0K
230.7K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
$422,161,000.00
$9,097,692.00
Revenue This Year
$5.92
N/A
Revenue Next Year
$4.06
$32.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$1.26
$0.40
52 Week High
$3.10
$1.15

Technical Indicators

Market Signals
Indicator
BRLT
NMTC
Relative Strength Index (RSI) 47.43 39.58
Support Level $1.34 $0.57
Resistance Level $1.65 $0.72
Average True Range (ATR) 0.10 0.07
MACD 0.01 -0.01
Stochastic Oscillator 73.68 11.78

Price Performance

Historical Comparison
BRLT
NMTC

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: